France’s public health agency, the Haute Autorité de Santé (HAS), has temporarily suspended the use of Valneva’s vaccine Ixchiq in adults ages 65 years and older as authorities investigate ...

French health authorities have suspended the use of Valneva’s chikungunya vaccine Ixchiq in adults aged 65 and older after serious adverse events – including one death – were reported during ...

That’s a lot of Leicesters, and you’ll want to pronounce them correctly. It’s “Less-stuh” — the “cester” is a tricksy suffix we’ll return to presently. It has a picturesque ...

Shares in Valneva plunged after the company said France's health authorities suspended the use of its chikungunya vaccine, Ixchiq, for people aged 65 and older, raising concerns about the vaccine ...

Healthcare: Merck KGaA [MRK.DE] -0.5% (acquires Springworks at $47/shr in cash), Valneva [VLA.FR] -7.0% (French health authorities decided to suspend the use of IXCHIQ in persons aged 65 years and ...

The French biotech is the first company to bring a chikungunya vaccine to market, getting FDA approval for its Ixchiq (VLA1553) shot in November 2023 and in Europe and Canada in June, for adults ...

Valneva's Ixchiq vaccine – which was cleared in the EU, the US, and Canada last year – is currently indicated for preventing chikungunya disease in adults only, although, it is in clinical ...

The ACIP voted to recommend a precaution related to the use of Ixchiq in patients aged 65 years and older. Recommendations for the use of chikungunya vaccine were recently discussed at a meeting of ...

This isn’t the first time Japanese gamers have simplified a foreign title. Many games, movies, and brands receive shortened or localized names to make them easier to say. For example: ...